A total of 11 patients (16.2%) had negative serology for both anti-AChR and anti-MuSK. This is the first study in Chile where RIA tests were used to confirm the diagnosis of MG in compliance with international guidelines. The gene discussed is MUSK; the disease is myasthenia gravis.